Tibet Rhodiola Pharmaceutical Holding Co. Class ASSE: 600211

Announcement on Obtaining Approval Notice for Drug Supplement Application by Wholly-Owned Subsidiary

· Issued by Tibet Rhodiola Pharmaceutical Holding Co. Class A via Shanghai Stock Exchange
Announcement on Obtaining Approval Notice for Drug Supplement Application by Wholly-Owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment